DreaMed Diabetes

DreaMed Diabetes is a technology focused company that specializes in creating solutions for managing and treating diabetes. The company developed an AI-based digital diabetes management platform known as Advisor Pro. This platform is designed to help healthcare professionals optimize insulin therapy plans for people with diabetes. Advisor Pro uses AI technology to analyze medical and behavioral data, providing personalized insulin treatment plans. Thus, it aims to make the treatment process more efficient and tailored specifically to the needs of each individual patient.

Founded in 2014, DreaMed Diabetes is committed to making diabetes management simpler and more precise. Their goal is to help both healthcare providers and patients better manage the disease and improve quality of life. The company not only offers a platform for professionals, but also provides a patient app, GlucoSitter, which offers real-time glucose predictions and insulin dose recommendations. Through their technology, DreaMed Diabetes provides practical tools for personalized and data-driven diabetes care.